ArticleJCI insight2024

Indoleamine-2,3-dioxygenase inhibition improves immunity and is safe for concurrent use with cART during Mtb/SIV coinfection.

Bindu Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.